| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060843A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | WO2001060807A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | WO2001060784A1 Aniline-derived ligands for the thyroid receptor |
| 08/23/2001 | WO2001060409A1 Improved paste formulations |
| 08/23/2001 | WO2001060396A2 Method for treating thyroid disorders |
| 08/23/2001 | WO2001060394A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060376A1 Male contraceptive formulation comprising norethisterone |
| 08/23/2001 | WO2001060372A2 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016586 Use of organic compounds |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | CA2400627A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | CA2399822A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | CA2398063A1 Male contraceptive formulation comprising norethisterone |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1125579A2 Uses of agrp-melanocortin receptor binding modulating compounds |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 08/22/2001 | EP1124840A1 Ovary-specific genes and proteins |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124603A1 Vaporizing device for administering sterile medication |
| 08/22/2001 | EP1124592A2 Textured and porous silicone rubber |
| 08/22/2001 | EP1124535A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 08/22/2001 | EP0831787B1 Composition for sustained release of human growth hormone |
| 08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 08/22/2001 | CN1309637A Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
| 08/22/2001 | CN1309635A Benzocycloheptenes, method for production thereof, pharmaceutical preparations contg. these compounds, and their use for producing medicaments |
| 08/22/2001 | CN1308972A Hypoglycemic chip |
| 08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277869 Pharmaceutical composition |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/16/2001 | WO2001059448A1 Method of screening antiandrogen agent |
| 08/16/2001 | WO2001059127A2 Drug metabolizing enzymes |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058919A2 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058855A1 Use of androgen receptor suppressors |
| 08/16/2001 | WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 08/16/2001 | WO2001058489A1 Preventives/remedies for postoperative stress |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 08/16/2001 | WO2001007628A3 Human synthetases |
| 08/16/2001 | WO2001002569A3 Human immune response molecules |
| 08/16/2001 | WO1999050658A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | EP1144997A3 Methods and compounds for modulating nuclear receptor activity |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123098A1 Method for treating hot flashes in humans |
| 08/16/2001 | EP1123084A1 Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients |
| 08/16/2001 | EP1123008A2 Preparation and use of solidified oils |
| 08/16/2001 | EP0839137B1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 08/16/2001 | DE10004858A1 Verwendung von Proteinkinase-Inhibitor-alpha The use of protein kinase inhibitor alpha- |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2398956A1 A pharmaceutical composition for prophylaxis or therapy of a postoperative stress |
| 08/15/2001 | CN1308673A Modifing the expression of the FSH beta gene by homologous recombination |
| 08/15/2001 | CN1308630A Benzocarbazole and indenoindole derived estrogenic agents |
| 08/15/2001 | CN1308609A Method of locking 1 & alpha, -OH of vitamin d compounds in axial orientation |
| 08/15/2001 | CN1308544A Treatment for diabetes |
| 08/15/2001 | CN1308528A Plaster which contains steroids, and method for the production and use thereof |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274605 Administering an insulin sensitivity enhancer with an angiotensin converting enzyme inhibitor to reduce side effects to a diabetic patient |
| 08/14/2001 | US6274584 Peptide derivatives; bioavailability; enzyme resistance; milk and wool production |
| 08/09/2001 | WO2001057261A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056590A2 Utilization of protein kinase inhibitor alpha |
| 08/09/2001 | WO2001032596A8 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 08/09/2001 | WO2001006988A3 Super-active porcine growth hormone releasing hormone analog |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000055072A3 Aerosol metering valve |
| 08/09/2001 | WO2000045795A3 Topical sprays comprising a film forming composition |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/08/2001 | EP1121449A1 Delivery system for porcine somatotropin |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121125A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 08/08/2001 | EP1121100A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |